Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Onchidal: a naturally occurring irreversible inhibitor of acetylcholinesterase with a novel mechanism of action.

Abramson SN, Radic Z, Manker D, Faulkner DJ, Taylor P.

Mol Pharmacol. 1989 Sep;36(3):349-54.

PMID:
2779521
2.

A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate.

Rosenberry TL, Mallender WD, Thomas PJ, Szegletes T.

Chem Biol Interact. 1999 May 14;119-120:85-97.

PMID:
10421442
3.
4.

Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket.

Ordentlich A, Barak D, Kronman C, Flashner Y, Leitner M, Segall Y, Ariel N, Cohen S, Velan B, Shafferman A.

J Biol Chem. 1993 Aug 15;268(23):17083-95.

5.

1-Bromopinacolone, an active site-directed covalent inhibitor for acetylcholinesterase.

Cohen SG, Lieberman DL, Hasan FB, Cohen JB.

J Biol Chem. 1982 Dec 10;257(23):14087-92.

8.

A putative kinetic model for substrate metabolisation by Drosophila acetylcholinesterase.

Stojan J, Marcel V, Estrada-Mondaca S, Klaebe A, Masson P, Fournier D.

FEBS Lett. 1998 Nov 27;440(1-2):85-8.

9.

Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands.

Szegletes T, Mallender WD, Rosenberry TL.

Biochemistry. 1998 Mar 24;37(12):4206-16.

PMID:
9521743
10.

Novel allosteric sites on human erythrocyte acetylcholinesterase identified by two monoclonal antibodies.

Olson CE, Chhajlani V, August JT, Schmell ED.

Arch Biochem Biophys. 1990 Mar;277(2):361-7.

PMID:
1689985
11.

Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.

Johnson JL, Cusack B, Davies MP, Fauq A, Rosenberry TL.

Biochemistry. 2003 May 13;42(18):5438-52.

PMID:
12731886
12.

Selective effects of carbamate pesticides on rat neuronal nicotinic acetylcholine receptors and rat brain acetylcholinesterase.

Smulders CJ, Bueters TJ, Van Kleef RG, Vijverberg HP.

Toxicol Appl Pharmacol. 2003 Dec 1;193(2):139-46.

PMID:
14644616
13.

Reversible and irreversible inhibitory activity of succinic and maleic acid derivatives on acetylcholinesterase.

Trujillo-Ferrara J, Vázquez I, Espinosa J, Santillan R, Farfán N, Höpfl H.

Eur J Pharm Sci. 2003 Apr;18(5):313-22.

PMID:
12694883
14.

Oxadiazolidinones: irreversible inhibition of cholinesterases and effects on acetylcholine receptors.

Bakry NM, Sherby SM, Eldefrawi AT, Eldefrawi ME.

Neurotoxicology. 1986 Fall;7(3):1-10.

PMID:
3822252
16.
17.

Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities.

Katz EJ, Cortes VI, Eldefrawi ME, Eldefrawi AT.

Toxicol Appl Pharmacol. 1997 Oct;146(2):227-36.

PMID:
9344890
18.

In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.

Petroianu GA, Arafat K, Nurulain SM, Kuca K, Kassa J.

J Appl Toxicol. 2007 Mar-Apr;27(2):168-75.

PMID:
17265452
19.

alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.

Groebe DR, Dumm JM, Levitan ES, Abramson SN.

Mol Pharmacol. 1995 Jul;48(1):105-11.

PMID:
7623764
20.

Topology of ligand binding sites on the nicotinic acetylcholine receptor.

Arias HR.

Brain Res Brain Res Rev. 1997 Oct;25(2):133-91. Review.

PMID:
9403137

Supplemental Content

Support Center